Misplaced Pages

Gaboxadol: Difference between revisions

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 09:17, 25 October 2011 editBeetstra (talk | contribs)Edit filter managers, Administrators172,099 edits Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'CAS_number').← Previous edit Revision as of 09:18, 25 October 2011 edit undoBeetstra (talk | contribs)Edit filter managers, Administrators172,099 edits Script assisted update of identifiers for the Chem/Drugbox validation project (updated: '').Next edit →
Line 26: Line 26:
<!--Identifiers--> <!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}} | CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = <!-- blanked - oldvalue: 64603-91-4 --> | CAS_number = 64603-91-4
| ATC_prefix = none | ATC_prefix = none
| ATC_suffix = | ATC_suffix =

Revision as of 09:18, 25 October 2011

Pharmaceutical compound
Gaboxadol
Clinical data
ATC code
  • none
Identifiers
IUPAC name
  • 4,5,6,7-tetrahydroisoxazolopyridin-3(2H)-one
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.059.039 Edit this at Wikidata
Chemical and physical data
FormulaC6H8N2O2
Molar mass140.14 g/mol g·mol
3D model (JSmol)
SMILES
  • O=C1/C2=C(\ON1)CNCC2
InChI
  • InChI=1S/C6H8N2O2/c9-6-4-1-2-7-3-5(4)10-8-6/h7H,1-3H2,(H,8,9)
  • Key:ZXRVKCBLGJOCEE-UHFFFAOYSA-N
  (what is this?)  (verify)

Gaboxadol also known as 4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol (THIP) is an experimental sleep aid drug developed by Lundbeck and Merck. In March, 2007, Merck and H. Lundbeck cancelled work on the drug, citing safety concerns and the failure of an efficacy trial. It acts on the GABA system, but in a very different way from benzodiazepines and Z-drugs (zolpidem, zaleplon, etc). Lundbeck states that gaboxadol also increases deep sleep (stage 4).

See also

References

  1. US Patent 4278676 - Heterocyclic compounds

External links

Hypnotics/sedatives (N05C)
GABAA
Alcohols
Barbiturates
Benzodiazepines
Carbamates
Imidazoles
Monoureides
Neuroactive steroids
Nonbenzodiazepines
Phenols
Piperidinediones
Quinazolinones
Others
GABAB
H1
Antihistamines
Antidepressants
Antipsychotics
α2-Adrenergic
5-HT2A
Antidepressants
Antipsychotics
Others
Melatonin
Orexin
α2δ VDCC
Others
Hypnotics/sedatives (N05C)
GABAA
Alcohols
Barbiturates
Benzodiazepines
Carbamates
Imidazoles
Monoureides
Neuroactive steroids
Nonbenzodiazepines
Phenols
Piperidinediones
Quinazolinones
Others
GABAB
H1
Antihistamines
Antidepressants
Antipsychotics
α2-Adrenergic
5-HT2A
Antidepressants
Antipsychotics
Others
Melatonin
Orexin
α2δ VDCC
Others
GABA receptor modulators
Ionotropic
GABAATooltip γ-Aminobutyric acid A receptor
GABAATooltip γ-Aminobutyric acid A-rho receptor
Metabotropic
GABABTooltip γ-Aminobutyric acid B receptor
See also
Receptor/signaling modulators
GABAA receptor positive modulators
GABA metabolism/transport modulators


Stub icon

This sedative-related article is a stub. You can help Misplaced Pages by expanding it.

Categories:
Gaboxadol: Difference between revisions Add topic